Can Platelet-Rich Plasma (PRP) Help Reactivate Dormant Hair Follicles in Men and Women with Thinning Hair?

Hair thinning is not only a cosmetic issue but also a biological process that reflects cellular aging, hormonal imbalance, and microvascular deterioration. In recent years, Platelet-Rich Plasma (PRP) has emerged as a possible tool to awaken dormant hair follicles in both men and women. However, understanding how this process occurs—and how well it actually works—requires examining the available scientific evidence critically rather than accepting clinical promises at face value.

Platelets: Microscopic Agents of Repair

Platelets are small, anucleate cell fragments circulating in the bloodstream, primarily known for their role in hemostasis (blood clotting). Beyond this, they contain hundreds of bioactive molecules stored in their alpha granules, including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and insulin-like growth factor 1 (IGF-1). When released, these molecules initiate and regulate processes such as angiogenesis (formation of new blood vessels), fibroblast activation, and tissue remodeling.

In the scalp, these same mechanisms may influence hair follicle biology. Hair follicles alternate between three phases: the anagen phase (growth), catagen phase (transition), and telogen phase (rest). In individuals with androgenetic alopecia or other forms of hair thinning, a large number of follicles remain trapped in the telogen phase. The biological rationale for PRP is that its growth factors can signal these follicles to re-enter the anagen phase by enhancing oxygenation, nutrient diffusion, and dermal papilla cell metabolism.

PRP: The Autologous Growth Factor Reservoir

Platelet-Rich Plasma is derived from a patient’s own blood through centrifugation, which separates plasma enriched with platelets from red and white blood cells. This plasma is then re-injected into the scalp. The concentration of platelets is typically three to five times higher than in normal blood. Upon injection, platelets are activated—either mechanically by the needle or chemically using calcium chloride—releasing their stored growth factors in a controlled manner.

The treatment aims to create a microenvironment of regeneration, stimulating hair follicle stem cells and dermal papilla cells, two populations essential for hair formation and cycling. Through these interactions, PRP may theoretically induce angiogenesis and extracellular matrix remodeling, two conditions necessary for dormant follicles to resume growth. However, it is important to emphasize that while this biological mechanism is plausible, results vary widely depending on the preparation method, patient profile, and injection technique.

What the Research Actually Shows

In 2015, Gentile and colleagues in Italy ran a randomized, evaluator-blinded, placebo-controlled half-head trial in men with pattern hair loss (23 enrolled, 3 excluded). PRP was injected on one half of the scalp and placebo on the other, in three sessions 30 days apart. After the third session, the authors reported a mean increase of 33.6 hairs in the target area and 45.9 hairs per cm² in total hair density compared with baseline; the abstract does not give the difference from the placebo side. Four patients had progressive hair loss again after 12 months and were re-treated (Gentile et al., 2015). The authors also reported more Ki-67-positive (dividing) cells in treated skin. The trial was small and included only men.

A 2017 meta-analysis by Gupta and Carviel found 13 studies but could pool data from only four trials (60 participants). It described PRP as an off-label treatment and the evidence as preliminary.

A 2023 meta-analysis of 9 randomized trials (238 patients) found higher hair density with PRP than with placebo at 3 and 6 months, but no significant difference from placebo in hair count or hair thickness (Zhang et al., 2023). Variations in platelet concentration, activation methods and injection frequency make the studies hard to compare.

What Happens at the Cellular Level?

Once injected, PRP is thought to act on the dermal papilla, the specialized cluster of mesenchymal cells located at the follicle base. These cells orchestrate the transition between hair growth phases by regulating epithelial stem cell activity. In laboratory studies, growth factors such as IGF-1 and EGF bind to cellular receptors, activating intracellular signaling pathways that promote cell proliferation and angiogenesis. Increased expression of Ki-67, a protein marker of cell division, was reported in treated skin in the Gentile 2015 trial, suggesting that follicular cells become more active.

Moreover, PRP’s anti-inflammatory cytokines may reduce oxidative stress, a biochemical state that damages DNA and impairs hair follicle function. This restorative effect on the follicular microenvironment may explain why some patients experience a return of vellus (fine) hairs and gradual thickening of existing strands. Nonetheless, these effects are not guaranteed, and a considerable number of patients report minimal or no improvement.

Evaluating Limitations and Safety

Despite the promise, several limitations persist. Most studies have short follow-up periods—typically three to six months—and rarely assess outcomes beyond one year. PRP preparation methods differ significantly between clinics, with no consensus on the ideal platelet concentration or activation technique. In addition, patient variability—including hormonal status, nutrition, and degree of follicle miniaturization—affects outcomes.

PRP for hair loss is off-label: the devices used to prepare PRP are FDA-cleared for processing blood, but no PRP product is FDA-approved to treat hair loss (Gupta & Carviel, 2017; Paichitrojjana & Paichitrojjana, 2022). Long-term safety data are limited. Reported side effects are usually mild and temporary, such as pain during injection, redness or swelling.

PRP is not suitable for people with platelet disorders, a very low platelet count, or an infection at the injection site (Paichitrojjana & Paichitrojjana, 2022). Tell the clinician about all medicines first, especially blood-thinning (anticoagulant or antiplatelet) medicines and anti-inflammatory painkillers; never stop a prescribed blood thinner without advice from the prescribing doctor.

The Critical Takeaway

**PRP does not replace established treatments like minoxidil or finasteride, nor does it guarantee follicular reactivation for everyone. **It uses the body’s own platelet signals in an attempt to awaken dormant follicles. For patients considering this procedure, it is crucial to understand that its success depends on multiple variables and that the evidence, though growing, is not yet definitive. The mechanism is plausible, but clinical evidence is limited to small, short trials.

---

References

Gentile, P., Garcovich, S., Bielli, A., Scioli, M. G., Orlandi, A., & Cervelli, V. (2015). The effect of platelet-rich plasma in hair regrowth: A randomized placebo-controlled trial. Stem Cells Translational Medicine, 4(11), 1317–1323. https://pubmed.ncbi.nlm.nih.gov/26400925/

Gupta, A. K., & Carviel, J. L. (2017). Meta-analysis of efficacy of platelet-rich plasma therapy for androgenetic alopecia. Journal of Dermatological Treatment, 28(1), 55–58. https://pubmed.ncbi.nlm.nih.gov/27152474/

Paichitrojjana, A., & Paichitrojjana, A. (2022). Platelet rich plasma and its use in hair regrowth: A review. Drug Design, Development and Therapy, 16, 635–645. https://pubmed.ncbi.nlm.nih.gov/35300222/

Zhang, X., Ji, Y., Zhou, M., et al. (2023). Platelet-rich plasma for androgenetic alopecia: A systematic review and meta-analysis of randomized controlled trials. Journal of Cutaneous Medicine and Surgery, 27(5), 504–508. https://pubmed.ncbi.nlm.nih.gov/37533146/